In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers

International Journal of Biological Macromolecules

Volumn 50, Issue 3, 2012, Pages 523-529

  Jia, Lejiao ^a   Shen, Jingyi ^a   Zhang, Dianrui ^a   Duan, Cunxian ^a   Liu, Guangpu ^a   Zheng, Dandan ^a   Tian, Xiaona ^a   Liu, Yue ^a   Zhang, Qiang ^b  

^a SHANDONG UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

In vitro release properties; Long circulating; Nanostructured lipid carriers; Oridonin; Pharmacokinetics

Indexed keywords

GLYCEROL STEARATE; MACROGOL; MACROGOL 2000; MEDIUM CHAIN TRIACYLGLYCEROL; NANOMATERIAL; ORIDONIN; STEARIC ACID;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG RELEASE; DRUG RETENTION; DRUG SCREENING; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MEAN RESIDENCE TIME; NONHUMAN; PARTICLE SIZE; RAT; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84863246118     PISSN: 01418130     EISSN: 18790003     Source Type: Journal    
DOI: 10.1016/j.ijbiomac.2012.01.024     Document Type: Article

References (25)

1. Zhang D.R., Ren T.C. Chin. Pharm. J. 2003, 38:817-820.
2. Wang H., Ye Y., Pan S.Y., Zhu G.Y., Li Y.W., Fong D.W., Yu Z.L. Phytomedicine 2011, 18:163-169.
3. Ji C.R., Feng W.S., Hu R.H., Su Y.L., Xia Z.T. Chin. J. Mod. Appl. Pharm. 1999, 16:35-36.
4. Chen S., Gao J., Halicka H.D., Huang X., Traganos F., Darzynkiewicz Z. Int. J. Oncol. 2005, 26:579-588.
5. Ren K.K., Wang H.Z., Xie L.P., Chen D.W., Liu X., Sun J., Nie Y.C., Zhang R.Q. J. Ethnopharmacol. 2006, 103:176-180.
6. Li S., Liu Y., Liu T., Zhao L., Zhao J., Feng N. Int. J. Pharm. 2011, 411:172-177.
7. Duan C., Zhang D., Wang F., Zheng D., Jia L., Feng F., Liu Y., Wang Y., Tian K., Zhang Q. Int. J. Pharm. 2011, 409:252-259.
8. Gao L., Zhang D., Chen M., Zheng T., Wang S. Drug Dev. Ind. Pharm. 2007, 33:1332-1339.
9. Müller R.H., Maaßen S., Weyhers H., Specht J.S. Int. J. Pharm. 1996, 138:85-94.
10. Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., Yang C.Z. J. Control. Release 1999, 59:299-307.
11. Müller R.H., Radtke M., Wissing S.A. Adv. Drug Deliv. Rev. 2002, 54(Suppl. 1):S131-S155.
12. Souto E.B., Wissing S.A., Barbosa C.M., Müller R.H. Int. J. Pharm. 2004, 278:71-77.
13. Jia L.J., Zhang D.R., Li Z.Y., Feng F.F., Wang Y.C., Dai W.T., Duan C.X., Zhang Q. Drug Deliv. 2010, 17:11-18.
14. Joshi M., Patravale V. Int. J. Pharm. 2008, 346:124-132.
15. Cole A.J., David A.E., Wang J., Galban C.J., Yang V.C. Biomaterials 2011, 32:6291-6301.
16. Yoshizawa Y., Kono Y., Ogawara K., Kimura T., Higaki K. Int. J. Pharm. 2011, 412:132-141.
17. Maciel N.R., Reis P.G., Kato K.C., Vidal A.T. Toxicol. Lett. 2010, 199:234-238.
18. Shen J., Wang Y., Ping Q., Xiao Y., Huang X. J. Control. Release 2009, 137:217-223.
19. Jia L., Zhang D., Li Z., Duan C., Wang Y., Feng F., Wang F., Liu Y., Zhang Q. Colloids Surf. B: Biointerfaces 2010, 80:213-218.
20. Li X.W., Lin X.H., Zheng L.Q., Yu L., Lv F.F., Zhang Q.Q., Liu W.C. Colloid Surf. A 2008, 317:352-359.
21. Doktorovova S., Araujo J., Garcia M.L., Rakovsky E., Souto E.B. Colloids Surf. B: Biointerfaces 2010, 75:538-542.
22. Wan F., You J., Sun Y., Zhang X.G., Cui F.D., Du Y.Z., Yuan H., Hu F.Q. Int. J. Pharm. 2008, 359:104-110.
23. You J., Wan F., de-Cui F., Sun Y., Du Y.Z., Hu F.Q. Int. J. Pharm. 2007, 343:270-276.
24. Yuan H., Wang L.L., Du Y.Z., You J., Hu F.Q., Zeng S. Colloids Surf. B: Biointerfaces 2007, 60:174-179.
25. Sheng Y., Liu C., Yuan Y., Tao X., Yang F., Shan X., Zhou H., Xu F. Biomaterials 2009, 30:2340-2348.